Passage BIO, Inc.
Total Trades
42
Buys
10
Sells
20
Largest Trade
N/A
Insiders
11
Institutional Funds
21
Inst. Value
$1M+
Activist Filings
27
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Chou William | PRESIDENT AND CEO | SELL | $50K–$100K | 4K | $18.44 | Jan 12, 2026 |
| Chou William | PRESIDENT AND CEO | EXERCISE | N/A | 10K | — | Jan 12, 2026 |
| Borthwick Kathleen | CFO | EXERCISE | N/A | 5K | — | Jan 12, 2026 |
| Borthwick Kathleen | CFO | SELL | $15K–$50K | 2K | $18.44 | Jan 12, 2026 |
| Lynx1 Capital Management LP | 10% Owner | BUY | $100K–$500K | 32K | $6.99 | Sep 16, 2025 |
| Lynx1 Capital Management LP | 10% Owner | BUY | $500K+ | 129K | $5.70 | Jul 24, 2025 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $100K–$500K | 584K | $0.34 | Jun 26, 2025 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $50K–$100K | 236K | $0.33 | Apr 24, 2025 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $15K–$50K | 149K | $0.33 | Apr 17, 2025 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $100K–$500K | 223K | $0.64 | Jan 14, 2025 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $100K–$500K | 147K | $0.70 | Jan 8, 2025 |
| Lynx1 Capital Management LP | 10% Owner | BUY | $100K–$500K | 374K | $0.65 | Dec 31, 2024 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $100K–$500K | 230K | $0.60 | Dec 26, 2024 |
| Lynx1 Capital Management LP | 10% Owner | BUY | $100K–$500K | 456K | $0.62 | Nov 27, 2024 |
| ORBIMED ADVISORS LLC | 10% Owner | SELL | $15K–$50K | 39K | $0.71 | Sep 23, 2024 |
| Borthwick Kathleen | SVP, INTERIM CFO | SELL | $1K–$15K | 1K | $0.97 | Feb 14, 2024 |
| Borthwick Kathleen | SVP, INTERIM CFO | EXERCISE | N/A | 4K | — | Feb 14, 2024 |
| Forman Mark S | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | Feb 14, 2024 |
| Forman Mark S | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 2K | $0.97 | Feb 14, 2024 |
| Forman Mark S | Chief Medical Offi… | EXERCISE | N/A | 50K | — | Jan 3, 2024 |
| Forman Mark S | Chief Medical Offi… | SELL | $1K–$15K | 16K | $0.91 | Jan 3, 2024 |
| Borthwick Kathleen | SVP, Interim CFO | EXERCISE | N/A | 30K | — | Jan 3, 2024 |
| Borthwick Kathleen | SVP, Interim CFO | SELL | $1K–$15K | 11K | $0.91 | Jan 3, 2024 |
| Cale Edgar B. | GC & Corporate Sec… | EXERCISE | N/A | 50K | — | Jan 3, 2024 |
| Cale Edgar B. | GC & Corporate Sec… | SELL | $1K–$15K | 16K | $0.91 | Jan 3, 2024 |
| King Simona | CFO | SELL | $1K–$15K | 11K | $0.88 | Aug 1, 2023 |
| King Simona | CFO | EXERCISE | N/A | 31K | — | Aug 1, 2023 |
| ORBIMED ADVISORS LLC | 10% Owner | BUY | $1M+ | 1.2M | $0.84 | Jun 29, 2023 |
| Fotopoulos Alexandros | Chief Technical Of… | SELL | $1K–$15K | 4K | $0.93 | Jun 20, 2023 |
| Fotopoulos Alexandros | Chief Technical Of… | EXERCISE | N/A | 13K | — | Jun 20, 2023 |
| King Simona | CFO | EXERCISE | N/A | 6K | — | Apr 20, 2023 |
| King Simona | CFO | SELL | $1K–$15K | 2K | $1.05 | Apr 20, 2023 |
| Kapadia Sandip | Director | SELL | $1K–$15K | 5K | $1.19 | Dec 2, 2022 |
| Fotopoulos Alexandros | Chief Technical Of… | SELL | $1K–$15K | 4K | $1.33 | Nov 25, 2022 |
| Fotopoulos Alexandros | Chief Technical Of… | EXERCISE | N/A | 13K | — | Nov 25, 2022 |
| Toernsen Monika Maria | Chief Commercial O… | SELL | $1K–$15K | 2K | $1.51 | Nov 18, 2022 |
| Toernsen Monika Maria | Chief Commercial O… | EXERCISE | N/A | 5K | — | Nov 18, 2022 |
| ORBIMED ADVISORS LLC | 10% Owner | BUY | $1M+ | 525K | $1.94 | May 5, 2022 |
| Goldsmith Bruce A | CEO and President | BUY | $15K–$50K | 10K | $3.15 | Mar 23, 2022 |
| ORBIMED ADVISORS LLC | 10% Owner | BUY | $1M+ | 369K | $5.42 | Jan 24, 2022 |
| ORBIMED ADVISORS LLC | 10% Owner | BUY | $500K+ | 168K | $5.38 | Jan 20, 2022 |
| ORBIMED ADVISORS LLC | 10% Owner | BUY | $500K+ | 150K | $5.61 | Jan 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 21 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 109K | $1M+ | SH |
| Erste Asset Management GmbH | 85K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 26K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 24K | $100K–$500K | SH |
| VANGUARD GROUP INC | 18K | $100K–$500K | SH |
| Squarepoint Ops LLC | 11K | $100K–$500K | SH |
| FIDUCIARY TRUST CO | 11K | $100K–$500K | SH |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 10K | $100K–$500K | SH |
| BlackRock, Inc. | 2K | $15K–$50K | SH |
| BARCLAYS PLC | 212 | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 142 | $1K–$15K | SH |
| MORGAN STANLEY | 55 | <$1K | SH |
| Parallel Advisors, LLC | 16 | <$1K | SH |
| JPMORGAN CHASE & CO | 15 | <$1K | SH |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2 | <$1K | SH |
| LRI Investments, LLC | 12 | <$1K | SH |
| BNP PARIBAS FINANCIAL MARKETS | 12 | <$1K | SH |
| HARBOUR INVESTMENTS, INC. | 3 | <$1K | SH |
| UBS Group AG | 1 | <$1K | SH |
| TSFG, LLC | 5 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2025
19.6%
624K shares
SC 13D/A · Jul 24, 2025
4.3%
132K shares
SC 13D/A · Jul 21, 2025
7.8%
244K shares
SC 13D/A · Jul 10, 2025
9.5%
5.9M shares
SC 13D/A · Apr 25, 2025
10.7%
6.7M shares
SC 13G/A · Feb 14, 2025
15.0%
9.3M shares
SC 13D/A · Dec 26, 2024
12.0%
7.4M shares
SC 13G/A · Nov 14, 2024
4.4%
2.5M shares
SC 13G · Nov 14, 2024
5.4%
3.0M shares
SC 13G · Nov 14, 2024
9.9%
6.1M shares
Versant Venture Capital VI, L.P. 2.
SC 13D/A · Aug 9, 2024
0.0%
0 shares
SC 13G/A · Aug 9, 2024
13.6%
8.4M shares
Versant Venture Capital VI, L.P.
SC 13D/A · May 29, 2024
6.5%
4.0M shares
SC 13D/A · Apr 12, 2024
13.0%
8.0M shares
SC 13G · Mar 29, 2024
8.7%
4.8M shares
SC 13G/A · Feb 14, 2024
0.7%
379K shares
Versant Venture Capital VI, L.P.
SC 13D/A · Nov 9, 2023
7.3%
4.0M shares
SC 13D/A · Jun 29, 2023
14.7%
8.0M shares
Frazier Life Sciences IX, L.P.
SC 13D/A · Jun 15, 2023
4.7%
2.5M shares
SC 13G/A · Feb 14, 2023
5.1%
3.4M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G · Sep 29, 2022
5.1%
2.8M shares
Frazier Life Sciences IX, L.P.
SC 13D/A · Aug 15, 2022
6.9%
3.8M shares
SC 13G · Jul 8, 2022
2.5%
1.4M shares
SC 13D/A · May 5, 2022
12.6%
6.8M shares
SC 13G/A · Feb 14, 2022
6.0%
3.2M shares
SC 13G/A · Feb 14, 2022
4.8%
2.6M shares